Diagnóstica Longwood
  • esES
  • +34 976 320 638
  • M-T: 8.30-17.30 F:8.30-14.30
  • Catalog
    • Immunology and transplantation
      • HLA Typing
      • Allergy
      • Alloantibodies Detection
      • HLA-associated diseases
      • Chimerism
      • Immune response and biomarkers
      • Immunosequencing
      • Other – Immunology
    • Molecular Genetics
      • Cystic Fibrosis
      • Prenatal Diagnosis
      • Reproduction
      • Pharmacogenomics
      • Triplet Expansion
      • Genetic Panels
      • Other – Genetics
    • Hematology and blood bank
      • Blood Group Genotyping (RBC)
      • Platelet Antibody Testing
      • Thrombophilias and Hemochromatosis
      • Cryopreservation
      • Other – Hematology
    • Oncology
      • Solid Tumor
      • Oncohematology
    • Microbiology
      • Fungus
      • Syndromic
      • Sepsis
      • NGS
    • Preanalytics
      • Blood collection
      • Sampling and Extraction
      • Sample transportation
  • Company
    • Contact
    • Work with us
    • Our brands
  • Events
Login

Adellgene Friedreich’s Ataxia

CatalogMolecular GeneticsTriplet Expansion

Determination by fluorescent fragment analysis of the presence of healthy, premutated and mutated alleles of the FXN gene of Friedreich’s Ataxia

Friedreich’s Ataxia (FRDA) is the most common hereditary ataxia, with an estimated prevalence of 1 in 50.000 and a deduced carrier frequency of 1 in 120 in Europe populations. FRDA is an autosomal recessive degenerative disease characterized by a progressive degeneration of nervous tissue in the spinal cord, in particular sensory neurons essential (through connections with the cerebellum) for directing muscle movement of the arms and legs.

 Adellgene Friedreich’s Ataxia is a kit designed for detecting the number of repetitions of GAA in the first intron of the gene encoding frataxin (FXN) gene located in chromosome 9 resulting in Friedreich’s Ataxia disease. It aims to aid clinical diagnosis associated with clinical findings in Friedreich’s ataxia that span from mild to severe symptoms.

Adellgene Friedreich’s Ataxia allows the determination of healthy individuals who have 5 - 30 GAA repeats, patients with mild phenotype (30-49 repeats), and severe (50-1300).

The technology is based on the polymerase chain reaction (PCR) of genomic DNA extracted and purified from peripheral blood followed by fluorescence analysis of the size of the PCR fragments obtained by genetic analyzer and conversion of that size in the number of GAA repeats.

Related products

myChoice CDx PLUS

La prueba más completa para determinar el estado de deficiencia de la recombinación homóloga (HDR) estudiando los genes BRCA y 13 más adicionales, en pacientes con cáncer de ovario.
  • Certificado CE
  • Certificado IVD

myChoice CDx

The most comprehensive tumor test to determine Homologous Recombination Deficiency (HDR) Status by studying the BRCA genes in patients with ovarian cancer.
  • Certificado CE
  • Certificado IVD

EndoPredict®

Prognostic and predictive molecular in vitro test to determine the risk of recurrence and the absolute benefit of chemotherapy over the next 15 and 10 years, respectively, in patients with ER+/HER2- primary breast cancer.
  • Certificado CE
  • Certificado IVD
Genética molecular

Molecular Genetics

Blackhills Diagnostic Resources
  • Fragment Analysis
Request information - Adellgene Friedreich’s Ataxia

    Contact with the commercial department of Diagnóstica Longwood to request information and you will allow us to contact you commercially by email or telephone, complying with the European Data Protection regulations.

    You can unsubscribe when you want, rectify or limit your data.



    I consent to the use of my data to receive information and news

    In compliance with the provisions in the regulation General of protection of data 2016/679, DIAGNOSTICA LONGWOOD informs that its e-mail address, as well as other personal data that may be included in this form form part of a treatment of personal data whose features are detailed below: The controller of such processing will be DIAGNOSTICA LONGWOOD and the purpose will be to answer the queries raised by the user and to send him/her requested information, as well as to send information and news about our company, in case he/she has authorised it. By marking the consent, you are legitimising this use. DIAGNOSTICA LONGWOOD does not pass on data to third parties. You may at any time exercise your rights of access, rectification and deletion of your data, as explained in our Privacy Policy.


    Product families

    • Molecular Genetics
      • Prenatal Diagnosis
      • Triplet Expansion
      • Pharmacogenomics
      • Cystic Fibrosis
      • Other – Genetics
      • Genetic Panels
      • Reproduction
    • Hematology and blood bank
      • Platelet Antibody Testing
      • Cryopreservation
      • Blood Group Genotyping (RBC)
      • Other – Hematology
      • Thrombophilias and Hemochromatosis
    • Immunology and transplantation
      • Alloantibodies Detection
      • HLA-associated diseases
      • Immunosequencing
      • Other – Immunology
      • Chimerism
      • Immune response and biomarkers
      • HLA Typing
    • Microbiology
      • Fungus
      • NGS
      • Sepsis
      • Syndromic
    • Oncology
      • Oncohematology
      • Solid Tumor
    • Preanalytics
      • Sampling and Extraction
      • Blood collection
      • Sample transportation

    Diagnostica Longwood

    Customer Service:
    M-T 8.30 – 17.30 / F 8.30 – 14.30
    +34 976 320 638 – dlw@dlongwood.com

    • Quality Policy
    • Legal Warning
    • Privacy Policy
    • Cookie policy
    • Data Protection

    2021 © Diagnóstica Longwood SL

    We are using cookies to give you the best experience on our website.

    You can find out more about which cookies we are using or switch them off in settings.

    Powered by  GDPR Cookie Compliance
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

    Strictly Necessary Cookies

    Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

    If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

    3rd Party Cookies

    This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

    Keeping this cookie enabled helps us to improve our website.

    Please enable Strictly Necessary Cookies first so that we can save your preferences!

    Política de cookies

    Más información sobre nuestra política de cookies